Timeliness of childhood vaccinations in kampala uganda: A community-based cross-sectional study

PLoS ONE

Volumn 7, Issue 4, 2012, Pages

  Babirye, Juliet N ^a,b   Engebretsen, Ingunn M S ^b,c   Makumbi, Frederick ^a   Fadnes, Lars T ^b   Wamani, Henry ^a   Tylleskar, Thorkild ^b   Nuwaha, Fred ^a  

^a MAKERERE UNIVERSITY COLLEGE OF HEALTH SCIENCES   (Uganda)

^b UNIVERSITY OF BERGEN   (Norway)

^c HAUKELAND UNIVERSITY HOSPITAL   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

BCG VACCINE; MEASLES VACCINE; POLIOMYELITIS VACCINE;

ARTICLE; BCG VACCINATION; CHILD; CHILD HEALTH CARE; CROSS-SECTIONAL STUDY; HEALTH CARE FACILITY; HUMAN; INFANT; MEASLES VACCINATION; PRESCHOOL CHILD; SINGLE PARENT; SOCIOECONOMICS; TIME; UGANDA; VACCINATION; FEMALE; IMMUNIZATION; IMMUNOLOGY; INTERVIEW; MOTHER; PSYCHOLOGICAL ASPECT; STATISTICS;

BCG VACCINE; CROSS-SECTIONAL STUDIES; FEMALE; HUMANS; IMMUNIZATION SCHEDULE; INFANT; INTERVIEWS AS TOPIC; MEASLES VACCINE; MOTHERS; TIME FACTORS; UGANDA; VACCINATION;

EID: 84860011910     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0035432     Document Type: Article

References (29)

1. United Nations Inter-agency Group for Child Mortality Estimation (2011) Levels and trends in child mortality. Available: http://www.unicef.org/media/files/Child_Mortality_Report_2011_Final.pdf. Accessed 2011 Nov 23.
2. Levine OS, Bloom DE, Cherian T, de Quadros C, Sow S, et al. (2011) The future of immunisation policy, implementation, and financing. Lancet 378: 439-448.
3. WHO, UNICEF, World Bank (2009) State of the world's vaccines and immunization. 3rd edition Geneva World Health Organization ISBN 978 92 4 156386 4. Accessed 2010 Feb 2.
4. Bloom DE, (2011) The value of vaccination. Adv Exp Med Biol 697: 1-8.
5. Bloom DE, Mahal A, O'Flaherty B, (2005) Economic perspectives on injecting drug use. Adv Health Econ Health Serv Res 16: 371-395.
6. Akmatov MK, Kretzschmar M, Kramer A, Mikolajczyk RT, (2008) Timeliness of vaccination and its effects on fraction of vaccinated population. Vaccine 26: 3805-3811.
7. Fadnes LT, Nankabirwa V, Sommerfelt H, Tylleskar T, Tumwine JK, et al. (2011) Is vaccination coverage a good indicator of age-appropriate vaccination? A prospective study from Uganda. Vaccine 29: 3564-3570.
8. Luman ET, Barker LE, Shaw KM, McCauley MM, Buehler JW, et al. (2005) Timeliness of childhood vaccinations in the United States: days undervaccinated and number of vaccines delayed. JAMA 293: 1204-1211.
9. HMIS (2007-2008) Health Management Information Systems. Kampala District Profile Annual Report. Office of the District Director of Health services. Kampala.
10. Mbabazi WB, Nanyunja M, Makumbi I, Braka F, Baliraine FN, et al. (2009) Achieving measles control: lessons from the 2002-06 measles control strategy for Uganda. Health Policy Plan 24: 261-269.
11. Moxon ER, Siegrist CA, (2011) The next decade of vaccines: societal and scientific challenges. Lancet 378: 348-359.
12. UDHS (2006) Uganda Demographic and Health Survey 2006. Uganda Bureau of Statistics (UBOS) and Macro International Inc Calverton, Maryland, USA UBOS and Macro International Inc.
13. Bennett S, Woods T, Liyanage WM, (1991) A simplified general method for cluster-sample surveys of health in developing countries. World Health Stat Q 44: 98-106.
14. Uganda government (2008) Uganda Bureau of Statistics-Sub-national projections report central region: 2008-2012. pp. 5-7 Uganda Bureau of Statistics. Kampala.
15. WHO (1995) Physical status: The use and interpretation of anthropometry Geneva.
16. Garza C, de Onis M, (2004) Rationale for developing a new international growth reference. Food Nutr Bull 25: S5-14.
17. Filmer D, Pritchett LH, (2001) Estimating wealth effects without expenditure data-or tears: an application to educational enrollments in states of India. Demography 38: 115-132.
18. Clark A, Sanderson C, (2009) Timing of children's vaccinations in 45 low-income and middle-income countries: an analysis of survey data. Lancet 373: 1543-1549.
19. Fadnes LT, Jackson D, Engebretsen IM, Zembe W, Sanders D, et al. (2011) Vaccination coverage and timeliness in three South African areas: a prospective study. BMC Public Health 11: 404.
20. Luman ET, Chu SY, (2009) When and why children fall behind with vaccinations: missed visits and missed opportunities at milestone ages. Am J Prev Med 36: 105-111.
21. Sadoh AE, Eregie CO, (2009) Timeliness and completion rate of immunization among Nigerian children attending a clinic-based immunization service. J Health Popul Nutr 27: 391-395.
22. Mupere E, Karamagi C, Zirembuzi G, Grabowsky M, de Swart RL, et al. (2006) Measles vaccination effectiveness among children under 5 years of age in Kampala, Uganda. Vaccine 24: 4111-4115.
23. Mutua MK, Kimani-Murage E, Ettarh RR, (2011) Childhood vaccination in informal urban settlements in Nairobi, Kenya: who gets vaccinated? BMC Public Health 11: 6.
24. Nankabirwa V, Tylleskar T, Tumwine JK, Sommerfelt H, (2010) Maternal education is associated with vaccination status of infants less than 6 months in Eastern Uganda: a cohort study. BMC Pediatr 10: 92.
25. Takum T, Padung D, Joshua V, Manickam P, Murhekar MV, (2011) Programmatic and beneficiary-related factors for low vaccination coverage in Papum Pare district, Arunachal Pradesh, India. J Trop Pediatr 57: 251-257.
26. Babirye JN, Rutebemberwa E, Kiguli J, Wamani H, Nuwaha F, et al. (2011) More support for mothers: a qualitative study on factors affecting immunisation behaviour in Kampala, Uganda. BMC Public Health 11: 723.
27. Ndiritu M, Cowgill KD, Ismail A, Chiphatsi S, Kamau T, et al. (2006) Immunization coverage and risk factors for failure to immunize within the Expanded Programme on Immunization in Kenya after introduction of new Haemophilus influenzae type b and hepatitis b virus antigens. BMC Public Health 6: 132.
28. Rahman M, Obaida-Nasrin S, (2010) Factors affecting acceptance of complete immunization coverage of children under five years in rural Bangladesh. Salud Publica Mex 52: 134-140.
29. Burgess DC, Burgess MA, Leask J, (2006) The MMR vaccination and autism controversy in United Kingdom 1998-2005: inevitable community outrage or a failure of risk communication? Vaccine 24: 3921-3928.